Etretinate enhances the susceptibility of human skin squamous cell carcinoma cells to 5-aminolaevulic acid-based photodynamic therapy

Clinical and Experimental Dermatology

Volumn 34, Issue 3, 2009, Pages 385-389

  Ishida, N ^a   Watanabe, D ^a   Akita, Y ^a   Nakano, A ^a   Yamashita, N ^a   Kuhara, T ^a   Yanagishita, T ^a   Takeo, T ^a   Tamada, Y ^a   Matsumoto, Y ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; AMINOLEVULINIC ACID; ETRETINATE; LIPOCORTIN 5; PROPIDIUM IODIDE; PROTOPORPHYRIN;

APOPTOSIS; ARTICLE; BIOACCUMULATION; CANCER CELL CULTURE; CELL KILLING; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; FLUORESCENCE; HUMAN; HUMAN CELL; IN VITRO STUDY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TREATMENT RESPONSE;

AMINOLEVULINIC ACID; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL DEATH; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION; DRUG SYNERGISM; ETRETINATE; HUMANS; KERATOLYTIC AGENTS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 62449314818     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2008.03003.x     Document Type: Article

References (16)

1. Kalka K, Merk H, Mukhtar H. Photodynamic therapy in dermatology. J Am Acad Dermatol 2000 42 : 389 413.
2. Peng Q, Berg K, Warioe T et al. A5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 1997 79 : 2282 308.
3. Kitajima Y, Mori S. Effects of retinoid (Ro 10-9359) on the plasma membrane of keratinocytes in patients with psoriasis: a freeze-fracture analysis. J Invest Dermatol 1983 80 : 174 80.
4. Tsambaos D, Mahrle G, Orfanos CE. Epidermal changes induced by oral excess of aromatic retinoid in guinea pigs. Arch Dermatol Res 1980 267 : 141 52.
5. Watson AB. Preventative effect of etretinate therapy on multiple actinic keratoses. Cancer Detect Prev 1986 9 : 161 5.
6. Moriarty M, Dunn J, Darragh A et al. Etretinate in treatment of actinic keratosis. A double-blind crossover study. Lancet 1982 1 : 364 5.
7. Szeimies RM, Karrer S. Towards a more specific therapy: targeting nonmelanoma skin cancer cells. Br J Dermatol 2006 154 : 16 21.
8. Bollag W, Holdener EE. Retinoids in cancer prevention and therapy. Ann Oncol 1992 3 : 513 26.
9. Tokuhashi K. The effects of etretinate and anticancer drugs on the cell line of a squamous cell carcinoma of human skin (HSC-1). Jpn J Dermatol B 1989 99 : 673 82.
10. Kobayashi K, Ninomiya T, Morita E et al. Antitumor effects of aromatic retinoids (Ro 10-1670, Ro 10-9359) on the chemically-induced epithelial tumors (in Japanese). Gan To Kagaku Ryoho 1982 9 : 457 66.
11. Kunisada M, Budiyanto A, Bito T et al. Retinoic acid suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma. Br J Dermatol 2005 152 : 435 43.
12. Ortel B, Sharlin D, O'Donnell D et al. Differentiation enhances aminolevulinic acid-dependent photodynamic treatment of LNCaP prostate cancer cells. Br J Cancer 2002 87 : 1321 7.
13. Sinha AK, Anand S, Ortel BJ et al. Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells. Br J Cancer 2006 95 : 485 95.
14. Ahmad N, Gipha S, Feyes DK et al. Involvement of Fas (APO-1/CD-95) during photodynamic-therapy-mediated apoptosis in human epidermoid carcinoma A431 cells. J Invest Dermatol 2000 115 : 1041 6.
15. Nakaseko H, Kobayashi M, Akita Y et al. Histological changes and involvement of apoptosis after photodynamic therapy for actinic keratoses. Br J Dermatol 2003 148 : 122 7.
16. Mrass P, Rendl M, Mildner M et al. Retinoic acid increases the expression of p53 and proapoptotic caspases and sensitizes keratinocytes to apoptosis: a possible explanation for tumor preventive action of retinoids. Cancer Res 2004 64 : 6542 8.